Abstract
Older generation antihistamines are empirically used in subjects with UACS, however the data about their efficacy share conflicting evidence. The effect on cough is believed to be mediated via antihistamine, anticholinergic and central sedative effects. Nowadays, attention is given to the new categories of histamine receptor antagonists (H4), which are abundantly expressed on the immune cells, nasal nerves and glands, decreasing severity of nasal inflammation. The aim of our study was to assess the efficacy of H4 receptor antagonist JNJ 7777120 (JNJ) on nasal symptoms magnitude and cough in ovalbumine (OVA) induced allergic rhinitis in guinea pigs.
Animals (n=15) were sensitized by intraperitoneal administration of OVA. Animals were repeatedly challenged with nasal OVA to induce allergic rhinitis and up-regulate cough reflex. When the reliability of the model was confirmed, animals were pretreated with JNJ (0.25 mg/kg and 0.5 mg/kg i.p. 30 minutes prior OVA administration). Cough was induced by inhalation of citric acid 0.4 M, for 10 minutes. Final count of coughs was confirmed using traces of sudden interruption of the basal breathing by cough pattern.
Allergic rhinitis up regulated the cough response from 11±2 to 19±3 cough per provocation, med±IQR, p <0.05. Pretreatment with 0.25 mg/kg showed a tendency to decrease cough responsiveness and suppress nasal symptoms, however the data did not reach significance. Dose 0.5 mg/kg significantly suppressed the nasal symptoms, and number of cough obtained during provocation from 19±3 to 10±1, med±IQR, p <0.05.Conclusion: JNJ in a dose 0.5mg/kg significantly suppressed the rhinitis symptoms and cough induced by citric acid.
- © 2014 ERS